Merit Medical Systems, Inc. (MMSI)

Merit Medical Systems Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	1,283	1,257	1,151	1,075	963.88	994.85
Revenue Growth (YoY)	9.39%	9.24%	7.09%	11.50%	-3.11%	12.70%
Cost of Revenue	686.08	673.49	631.88	589.42	562.7	562.49
Gross Profit	597.23	583.87	519.1	485.33	401.18	432.37
Selling, General & Admin	377.96	373.68	342.53	335.69	297.72	327.27
Research & Development	82.9	82.73	75.51	71.25	57.54	65.62
Other Operating Expenses	2.89	3.52	13.5	17.48	47.48	24.04
Operating Expenses	463.74	459.93	431.54	424.42	402.74	416.93
Operating Income	133.48	123.94	87.56	60.92	-1.56	15.43
Interest Expense / Income	21.55	15.51	6.34	5.26	9.99	12.41
Other Expense / Income	-9	-3.66	-1.41	1.74	1.68	0.83
Pretax Income	120.94	112.09	82.63	53.92	-13.23	2.19
Income Tax	18.99	17.68	8.11	5.46	-3.39	-3.26
Net Income	101.95	94.41	74.52	48.45	-9.84	5.45
Net Income Growth	20.40%	26.70%	53.79%	-	-	-87.03%
Shares Outstanding (Basic)	58	58	57	56	55	55
Shares Outstanding (Diluted)	59	58	58	57	55	56
Shares Change	0.66%	1.19%	0.54%	3.47%	-1.42%	4.27%
EPS (Basic)	1.77	1.64	1.31	0.86	-0.18	0.10
EPS (Diluted)	1.75	1.62	1.29	0.84	-0.18	0.10
EPS Growth	18.24%	25.58%	53.57%	-	-	-87.18%
Free Cash Flow	133.64	111.06	69.33	120.33	119.32	0.56
Free Cash Flow Per Share	2.31	1.93	1.22	2.14	2.15	0.01
Gross Margin	46.54%	46.44%	45.10%	45.16%	41.62%	43.46%
Operating Margin	10.40%	9.86%	7.61%	5.67%	-0.16%	1.55%
Profit Margin	7.94%	7.51%	6.47%	4.51%	-1.02%	0.55%
Free Cash Flow Margin	10.41%	8.83%	6.02%	11.20%	12.38%	0.06%
Effective Tax Rate	15.70%	15.77%	9.82%	10.13%	-	-148.56%
EBITDA	247.3	228.89	181.17	154.96	103.58	118.96
EBITDA Margin	19.27%	18.20%	15.74%	14.42%	10.75%	11.96%
Depreciation & Amortization	104.81	101.29	92.2	95.78	106.82	104.36
EBIT	142.48	127.6	88.97	59.18	-3.24	14.61
EBIT Margin	11.10%	10.15%	7.73%	5.51%	-0.34%	1.47%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).